文献速递消化道肿瘤与早癌

个人糖尿病史与结直肠癌家族史对结直肠癌风险同等重要:一项全国性队列研究

Personal History of Diabetes as Important as Family History of Colorectal Cancer for Risk of Colorectal Cancer: A Nationwide Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

基于瑞典全国性队列(1964-2015年随访,12,614,256人,其中糖尿病患者559,375例,结直肠癌患者162,226例),50岁前诊断糖尿病者50岁前结直肠癌风险为标准化的1.9倍(95%CI 1.6-2.3),50岁及以上为1.3倍(1.2-1.4)。有结直肠癌家族史者50岁前诊断糖尿病,50岁前结直肠癌风险为6.9倍(4.1-12),50岁及以上为1.9倍(1.4-2.5)。糖尿病患者50岁前结直肠癌终生风险为0.4%(0.3%-0.4%),与仅有结直肠癌家族史者0.5%(0.5%-0.5%)相近,为一般人群0.2%(0.2%-0.2%)的两倍。

要点

  • 50岁前诊断糖尿病者50岁前结直肠癌风险为1.9倍(95%CI 1.6-2.3)。
  • 有结直肠癌家族史且50岁前诊断糖尿病者50岁前结直肠癌风险为6.9倍(95%CI 4.1-12)。
  • 糖尿病患者50岁前结直肠癌终生风险0.4%与仅有家族史者0.5%相近,为人群0.2%的两倍。

核心结论

  • 糖尿病与结直肠癌风险增加相关,其幅度接近有结直肠癌家族史。
  • 糖尿病和结直肠癌家族史与结直肠癌风险增加的关联在年轻成人中最为突出。
  • 这些发现值得进一步研究糖尿病患者(尤其是2型糖尿病)在比一般人群更早年龄进行结直肠癌筛查的危害、获益和成本效益。

研究设计与样本

  • 全国性队列研究,使用瑞典家族癌症数据集、住院和门诊登记(随访1964-2015年)。
  • 纳入1931年后出生的所有个体及其父母,共12,614,256人,其中糖尿病患者559,375例,结直肠癌患者162,226例。

主要发现

  • 50岁前诊断糖尿病者50岁前结直肠癌风险为标准化的1.9倍(95%CI 1.6-2.3),50岁及以上结直肠癌风险为1.3倍(95%CI 1.2-1.4)。
  • 有结直肠癌家族史者50岁前诊断糖尿病,50岁前结直肠癌风险为6.9倍(95%CI 4.1-12),50岁及以上结直肠癌风险为1.9倍(95%CI 1.4-2.5)。
  • 糖尿病患者50岁前结直肠癌终生风险为0.4%(95%CI 0.3%-0.4%),仅有结直肠癌家族史者为0.5%(95%CI 0.5%-0.5%),一般人群为0.2%(95%CI 0.2%-0.2%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Diabetes mellitus (DM) and colorectal cancer (CRC) share some risk factors, including lifestyle and metabolic disturbances. We aimed to provide in-depth information on the association of CRC risk, especially early-onset CRC, with DM, family history of CRC, and age at DM diagnosis. METHODS: A nationwide cohort study was conducted using Swedish family cancer data sets, inpatient, and outpatient registers (follow-up: 1964-2015), including all individuals born after 1931 and their parents (12,614,256 individuals; 559,375 diabetic patients; 162,226 CRC patients). RESULTS: DM diagnosis before the age of 50 years was associated with a 1.9-fold increased risk of CRC before the age of 50 years (95% CI for standardized incidence ratio: 1.6-2.3) vs 1.3-fold risk of CRC at/after the age of 50 years (1.2-1.4). DM diagnosis before the age of 50 years in those with a family history of CRC was associated with 6.9-fold risk of CRC before the age of 50 years (4.1-12) and 1.9-fold risk of CRC at/after the age of 50 years (1.4-2.5). Diabetic patients had a similar lifetime risk of CRC before the age of 50 years (0.4%, 95% CI: 0.3%-0.4%) to those with only a family history of CRC (0.5%, 0.5%-0.5%), double that of the population (0.2%, 0.2%-0.2%). DISCUSSION: Our large cohort with valid information on DM and family history of cancer showed that DM is associated with increased risk of CRC in a magnitude close to having family history of CRC. Associations of DM and CRC family history with increased CRC risk were most prominent in young adults. These findings warrant further studies on harms, benefits, and cost-effectiveness of CRC screening in patients with diabetes, especially type 2, at earlier ages than in the general population.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ali Khan U, Fallah M, Tian Y, et al. Personal History of Diabetes as Important as Family History of Colorectal Cancer for Risk of Colorectal Cancer: A Nationwide Cohort Study. Am J Gastroenterol. 2020. PMID: 32618661. doi:10.14309/ajg.0000000000000669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。